Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015-2020
- PMID: 36541646
- PMCID: PMC10928949
- DOI: 10.1097/QAD.0000000000003431
Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015-2020
Abstract
Objective: To evaluate HIV care continuum trends over time among women with HIV (WWH).
Design: The Medical Monitoring Project (MMP) is a complex sample survey of adults with diagnosed HIV in the United States.
Methods: We used 2015-2019 MMP data collected from 5139 adults with diagnosed HIV infection who identified as cisgender women. We calculated weighted percentages with 95% confidence intervals (CIs) for all characteristics and estimated annual percentage change (EAPC) and the associated 95% CI to assess trends. EAPCs were considered meaningful from a public health perspective if at least 1% with P values less than 0.05.
Results: Among cisgender women with diagnosed HIV infection during 2015-2019, 58.8% were Black or African American (95% CI 54.4-63.3), 19% were Hispanic/Latina (95% CI 14.7-23.2), and 16% were Non-Hispanic White (95% CI 14.1-17.9) persons. There was a meaningful increase in the percentage who ever had stage 3 HIV disease from 55.8% (95% CI 51.0-60.5) in 2015 to 61.5% (95% CI 58.1-64.8) in 2019 (EAPC 1.7%; CI 1.5-1.9; P < 0.001). There were no meaningful changes over time among women, overall, in retention in care, antiretroviral therapy (ART) prescription, ART adherence, missed appointments, or recent or sustained viral suppression.
Conclusion: The HIV care continuum outcomes among WWH did not meaningfully improve from 2015 to 2019, raising a concern that Ending the HIV Epidemic in the US (EHE) initiative goals will not be met. To improve health and reduce transmission of HIV among WWH, multifaceted interventions to retain women in care, increase ART adherence, and address social determinants of health are urgently needed.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
There are no conflicts of interest.
References
- 
    - Centers for Disease Control and Prevention. HIV Surveillance Report, 2019; vol. 32. Available at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. [Accessed 25 May 2022]
 
- 
    - The White House. 2021. National HIV/AIDS Strategy for the United States 2022–2025. Washington, DC. Available at: https://www.whitehouse.gov/wp-content/uploads/2021/11/National-HIV-AIDS-.... [Accessed 25 May 2022]
 
- 
    - Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA 2019; 321:844–845. - PubMed
 
- 
    - May S, Murray A, Sutton MY. HIV infection among women in the United States: 2000–2017. AIDS Care 2020; 32:522–529. - PubMed
 
- 
    - Beer L, Johnson CH, Fagan JL, Frazier EL, Nyaku M, Craw JA, et al. A national behavioral and clinical surveillance system of adults with diagnosed HIV (The Medical Monitoring Project): protocol for an annual cross-sectional interview and medical record abstraction survey. JMIR Res Protoc 2019; 8:e15453. - PMC - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
- Miscellaneous
 
        